Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for FOREX trading professionals · Wednesday, June 26, 2019 · 489,076,301 Articles · 3+ Million Readers

Nuclear Medicine Market will grow at CAGR of 10.1% to hit $18.1 billion by 2025 - Global Outlook by Trends, Size, Share, Regulatory Framework, Porter’s Five Forces and Vendor Landscape Analysis: Adroit Market Research

Radioisotopes used in oncology application are expected to boost the nuclear medicine demand. In 2018, North America dominated the nuclear medicines market however, the Asian countries are expected to outpace other regions by 2025 growing with a CAGR of 13.3%.

/EIN News/ -- Dallas, Texas, May 23, 2019 (GLOBE NEWSWIRE) -- The nuclear medicine market is projected to reach USD 18.10 billion by 2025 growing with CAGR of 10.1% during the forecast period. The growing demand for radioisotopes in cancer imaging is a major driver for the nuclear medicine market.

The market research report on nuclear medicines evaluates the market demand, trends and opportunities for the period 2015 to 2025. The report highlights the historic trends from 2015 to 2017 with base estimates for 2018 and market forecast from 2019 to 2025. The report also studies the current status and future aspects the market at global as well as country level along with vendor landscape analysis and value chain analysis. The global nuclear medicine market has been segmented based on type, diagnostics and application. Furthermore, the report gives in-depth analysis of the market competitors along with company profiles of key manufacturers.

Request a PDF sample of the Global Nuclear Medicine market research report @ https://www.adroitmarketresearch.com/contacts/request-sample/59

Cancer is the most dreaded and leading cause of death worldwide. With the development of various radioisotopes for diagnostics in oncology, nuclear medicines have found new source of growth. Nuclear medicines are widely used for tumor localization, tumor staging, identifying metastatic sites and judging response to therapy.

The most common isotope used for diagnosis is Technetium-99 with around 40 million procedures performed worldwide. Technetium-99 is so adaptive that when it is taken up by a biologically active substance, its traces settle accurately into the tissue or organ of interest.

In diagnostic procedures, nuclear imaging serves a vital purpose in patient care. PET is more precise and sophisticated technique used for nuclear imaging as compared to SPECT. Moreover, hybrid imaging techniques such as PET-CT and PET-MRI are gaining traction these days due to improved functional information and reduced radiation exposure.

The “Global Nuclear Medicine Market Size 2018 by Type (Tc-99, I-131, F-18, Lu-177, Y-90, Others), Diagnostics (SPECT, PET), Application (Oncology, Neurology, Cardiology, Others), By Region (North America, Europe, APAC, and Rest of World) and Forecast 2018 to 2025” study provides an elaborative view of historic, present and forecasted market estimates.

North America will dominate the global nuclear medicine market in 2025 with more than 35% market share. Growth in this region is attributed to perpetual improvement and development of molecular imaging based diagnostics and treatment. However, Europe is expected to show lucrative growth in the foreseeable years as it is hub for isotope suppliers.

Direct purchase the Single user copy of the research study @ https://www.adroitmarketresearch.com/researchreport/purchase/59

The major players operating in the global nuclear medicine market include Curium, Nordion Inc., Cardinal Health Inc., Bracco Imaging S.p.A, Eczacibasi-Monrol Nükleer Ürünler San. ve Tic. A.S., Lantheus Medical Imaging, Inc., Jubilant Pharma. LLC, Ire-Elit SA, GE Healthcare Company, NTP and others. Due to the growing demand of nuclear medicines in health sciences, the players are forming strategic alliances and outsourcing the production of few radioisotopes to gain momentum in the industry. In line with this, Curium was founded in 2017, when IBA Molecular and Mallinckrodt Nuclear Medicine underwent partnership. This alliance was specifically formed to fulfill the growing demand of Technetium-99.

Major points from Table of Contents:

Chapter 1. Executive Summary
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4. Market Overview, By Type
Chapter 5. Market Overview, By Diagnostic Technique
Chapter 6. Market Overview, By Application
Chapter 7. Market Overview, By Region
Chapter 8. Company Profiles
Continued…

Grasp advance knowledge on Global Nuclear Medicine Industry through in-depth Blogs, White Paper & Infographics:

Access the White Paper “Nuclear Medicine Advanced Associate: What It Needs Right Now?” @ https://www.adroitmarketresearch.com/white-paper/nuclear-medicine-advanced-associate-what-it-needs-right-now

Read the in depth blog titled “Advantages And Disadvantages Of Nuclear Medicine” @ https://www.adroitmarketresearch.com/blogs/advantages-and-disadvantages-of-nuclear-medicine

Browse more related reports:

Global Orphan Drugs Market Size 2018-2025:
North America dominates the global orphan drugs market backed by its favorable government regulations and highly developed healthcare infrastructure. In North America, the U.S.A. accounts the largest market share due to rising awareness and economic incentives leading to higher growth of orphan drugs market. Further, higher investments to diagnose and treat the rare disease also helps the growth of orphan drug market. Browse the full report  @ https://www.adroitmarketresearch.com/industry-reports/orphan-drugs-market

Global Cancer Diagnostics Market Size 2018-2025:
The global cancer diagnostics market size is estimated to be over USD 12.8 billion by 2025. Cancer being the second largest disease worldwide, the increasing number of cancer cases and rise in healthcare expenditure has led to a growth in cancer diagnostics procedures. Cancer Market value is expected to grow at a CAGR of 4.5% during the forecast period. Browse the full report  @ https://www.adroitmarketresearch.com/industry-reports/cancer-diagnostics-market

Access research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html

About Us:
Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.


Contact Us:
Ryan Johnson
Account Manager - Global
3131 McKinney Ave Ste 600
Dallas, TX 75204
Email ID: sales@adroitmarketresearch.com
Phone No.: +1 (214) 884-6068
Connect with us: Facebook | Twitter | LinkedIn

logo.png

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release